Adaptive Biotechnologies Insider Sold: What Investors Should Know
Insider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
Recovering from budget neglect requires a clear plan: rebuild essential budgets, tackle debt strategically, and track progress weekly.
28,655 articlesInsider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
On Feb 26, The Trade Desk faced a sharp move as management guided softer revenue growth and rising margins strained b...
Netflix has shown strong momentum, but a stock price path hinges on more than business strength. This article breaks ...
Lenders are formalizing logging and review practices to protect loan data and title workflows amid rising cybersecuri...
A new round of claims alleges harassment at Carta, the private equity software unicorn valued near $7.4 billion. As m...
Bitget unveils Reality, a new tokenization platform delivering tokenized access to select U.S. stocks and ETFs as mar...
SpaceX signals a mega IPO that could raise up to $75 billion, potentially becoming the largest stock market debut in ...
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
Two benchmarks gave two opposite results for Claude Fable 5. The mystery isn't a nerf—it's the routing layer. Learn h...
Lawmakers’ stock trades tied to bills they’re about to vote on have renewed debate over whether current rules protect...
IonQ stock surged today after the company issued a revenue forecast that beat expectations, sparking a rally in the q...
Markets swing wildly during downturns, testing nerves and portfolios. Here are three stock market turmoil: crucial st...